Effect of BCG Polysaccharides Nucleic Acid on Immunologic Function in Patients with Chronic Obstructive Pulmonary Disease
Qian Jia-bei
Abstract
Qian Jia-bei
Abstract
OBJECTIVE:To study the effect of PSN polysaccharides nucleic acid on immunologic function in patients with chronic obstructive pulmonary disease(COPD).METHODS:60 COPD patients were randomly divided into 2 groups,COPD treatment group(n=30) and COPD control group(n=30).COPD treatment group received BCG-PSN polysaccharides nucleic acid(0.35 mg·mL-1 intramuscular injection,3 times a week) and conventional therapy while COPD control group only received conventional therapy.The patients in 2 groups were followed up for 1 month.T lymphocyte subpopulation(CD3+、CD4+、CD8+、CD4+/CD8+),NK and B lymphocyte percentages were determined before and after treatment.RESULTS:After treatment,CD4+,CD4+/CD8+ and B lymphocyte in COPD treatment group were significantly increased(P0.05),while CD8+ were decreased(P0.05).CD4+,CD4+/CD8+ and B lymphocyte in COPD treatment group were higher than COPD control group(P0.05) while CD8+ were decreased(P0.05).CONCLUSION:BCG-PSN can improve immunity in patients with COPD.It is of significance in the prevention and treatment of COPD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study the effect of PSN polysaccharides nucleic acid on immunologic function in patients with chronic obstructive pulmonary disease(COPD).METHODS:60 COPD patients were randomly divided into 2 groups,COPD treatment group(n=30) and COPD control group(n=30).COPD treatment group received BCG-PSN polysaccharides nucleic acid(0.35 mg·mL-1 intramuscular injection,3 times a week) and conventional therapy while COPD control group only received conventional therapy.The patients in 2 groups were followed up for 1 month.T lymphocyte subpopulation(CD3+、CD4+、CD8+、CD4+/CD8+),NK and B lymphocyte percentages were determined before and after treatment.RESULTS:After treatment,CD4+,CD4+/CD8+ and B lymphocyte in COPD treatment group were significantly increased(P0.05),while CD8+ were decreased(P0.05).CD4+,CD4+/CD8+ and B lymphocyte in COPD treatment group were higher than COPD control group(P0.05) while CD8+ were decreased(P0.05).CONCLUSION:BCG-PSN can improve immunity in patients with COPD.It is of significance in the prevention and treatment of COPD.
Key concepts: COPD, CD8, Medicine, Pulmonary disease, Immunology, Internal medicine, Immunity, Gastroenterology